TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Healius Limited ( (AU:HLS) ).
Healius Limited announced a change in the director’s interest, with Neil Vinson acquiring 17,045 ordinary shares at an average price of $0.88 per share through an on-market trade. This acquisition reflects a strategic move by the director, potentially signaling confidence in the company’s future performance and stability, which may influence stakeholder perceptions positively.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$0.87 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited operates in the healthcare sector, providing medical and diagnostic services. The company focuses on delivering healthcare solutions and services to a broad market, including pathology, imaging, and day hospitals.
YTD Price Performance: -14.17%
Average Trading Volume: 6,586,431
Technical Sentiment Signal: Sell
Current Market Cap: A$624.5M
See more insights into HLS stock on TipRanks’ Stock Analysis page.